Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Karmanos Cancer Institute first in Michigan to offer patients the Leksell Gamma Knife® Icon™

Offering patients the latest advancements in cancer care

Logo for the Barbara Ann Karmanos Cancer Institute (PRNewsFoto/Barbara Ann Karmanos Cancer ...)

News provided by

Barbara Ann Karmanos Cancer Institute

Aug 19, 2019, 14:23 ET

Share this article

Share toX

Share this article

Share toX

FARMINGTON HILLS, Mich., Aug. 19, 2019 /PRNewswire/ -- The Barbara Ann Karmanos Cancer Institute is the first cancer center in Michigan to acquire and treat patients with the new Leksell Gamma Knife® Icon™, the most precise stereotactic radiosurgery system (SRS) currently available to patients. This advanced technology and the special space built to accommodate it is part of the recent renovations completed at Karmanos Cancer Institute's outpatient treatment facility in Farmington Hills, Michigan – the Lawrence and Idell Weisberg Cancer Treatment Center.

Continue Reading
Karmanos Cancer Institute is the first cancer center in Michigan to acquire and treat patients with the new Leksell Gamma Knife® Icon™, the most precise stereotactic radiosurgery system currently available to patients. This advanced technology and the special space built to accommodate it is part of the recent renovations completed at Karmanos’ Lawrence and Idell Weisberg Cancer Treatment Center in Farmington Hills. The state-of-the-art Gamma Knife suite is the first in a two-phase expansion project. Karmanos’ phase two expansion is expected to be completed in 2022 and will include an additional $30 million investment to expand the facility to approximately 64,000 square feet, offering patients the most comprehensive cancer care.
Karmanos Cancer Institute is the first cancer center in Michigan to acquire and treat patients with the new Leksell Gamma Knife® Icon™, the most precise stereotactic radiosurgery system currently available to patients. This advanced technology and the special space built to accommodate it is part of the recent renovations completed at Karmanos’ Lawrence and Idell Weisberg Cancer Treatment Center in Farmington Hills. The state-of-the-art Gamma Knife suite is the first in a two-phase expansion project. Karmanos’ phase two expansion is expected to be completed in 2022 and will include an additional $30 million investment to expand the facility to approximately 64,000 square feet, offering patients the most comprehensive cancer care.
Karmanos Cancer Institute first in Michigan to offer patients the Leksell Gamma Knife® Icon™
Karmanos Cancer Institute first in Michigan to offer patients the Leksell Gamma Knife® Icon™

Karmanos neurosurgeons and radiation oncologists treated the first patient with the cutting edge Leksell Gamma Knife® Icon™ in June and have, to-date, treated 22 patients since, each successfully. Karmanos specialists can currently treat up to three patients a day with this precision therapy.  

"This specialized form of radiotherapy offers patients and physicians the most advanced technology for treating certain conditions; including metastatic brain tumors and benign conditions," said Justin Klamerus, M.D., MMM, president, Karmanos Cancer Hospital and Network. "We are excited to be the first in Michigan to offer patients this innovative treatment in an environment that optimizes the patient's experience."  

What is Gamma Knife® Icon™? 

Gamma Knife® Icon™ is a clinically proven radiosurgical method to treat select intracranial locations, such as the brain, brain stem or the trigeminal nerve. Gamma Knife does not involve a blade. Instead, this highly sophisticated non-invasive technology uses radiation beams to precisely target the tumor, sparing healthy brain and body tissue. Preserving tissue helps maintain normal function that can impact the patient's quality of life. 

How it Works

During an Icon™ treatment, up to 192 radiation beams are precisely directed to one or several intracranial lesions, so that the targeted tissue receives a concentrated dose of radiation. The source of radiation is cobalt, and the shape and dose of the radiation is optimized to focus on the exact location, without damaging healthy tissue or other parts of the body.

Once the patient is in position, MRI (magnetic resonance imaging) scans identify the exact location of the tumor in three dimensions, enabling neurosurgeons and radiation oncologists to direct the radiation beams to the target with unmatched precision. The actual treatment time can last from 30 minutes to two hours, depending on the tumor and target volume. Patients can listen to music during the surgical procedure and the physician communicates to the patient via intercom.

Patients are monitored closely and evaluated over time, returning for periodic follow-up imaging to review the results of treatment and to address any side effects.

Benefit to Patients

Michael Dominello, D.O., medical director for Gamma Knife Radiosurgery at Karmanos Cancer Institute, and assistant professor, Department of Oncology at Wayne State University School of Medicine, has seen first-hand the benefit this innovative technology has on patients.  

"One of the unique features of offering this precise Icon™ at our Farmington Hills location is that patients can receive this treatment in our beautiful and comfortable outpatient center instead of in a hospital setting," said Dr. Dominello. "From an expertise standpoint, the radiation oncologist, neurosurgeon and neuroradiologist are all on-site participating together as a team in the planning and reviewing of the final treatment plan, prior to the patient's treatment delivery. This is an uncommon practice but one that significantly enhances plan quality." 

Dr. Dominello went on to explain that the concept of an outpatient Gamma Knife facility is extremely unique. Most all Gamma Knife facilities are located in the basements of large hospitals, as was the case with the Gamma Knife that Karmanos previously had at its main campus in Detroit.

"The Leksell Gamma Knife® Icon™ allows us to treat brain tumors with precision accuracy using a frame-based or frameless immobilization system. The entire process, including MRI and PET (positron emission tomography) imaging services, happens under one roof in an intimate setting. Patients don't need to be transported to different locations within a hospital setting. Our Gamma Knife suite was designed to offer patients the expertise, comfort and convenience, all in one location."

Icon™ can be used to treat targets in the brain ranging from a few millimeters to several centimeters – including in areas of the brain that cannot be accessed with traditional surgery or are situated close to or inside critical areas, including brain stem, visual cortex and motor cortex. The Icon's non-invasive technique can be used as a standalone treatment for a variety of brain tumors and neurologic disorders, or as a "boost" following whole brain radiation therapy or surgical resection to decrease the risk of recurrence.

Unlike conventional radiation therapy which is delivered over the course of many treatment "fractions," Gamma Knife treatment is typically delivered in a single fraction. This treatment not only helps spare healthy brain tissue, it eliminates some of the side effects associated with more traditional therapies.

According to Dr. Dominello, patients go home following completion of the procedure and can generally resume normal activities the very next day.

Expanding Services at Karmanos' Farmington Hills Location

Karmanos' Lawrence and Idell Weisberg Cancer Treatment Center in Farmington Hills opened in 2001 with the purpose of making the state-of-the-science cancer services of the Barbara Ann Karmanos Cancer Institute in Detroit – one of the National Cancer Institute-designated Comprehensive Cancer Centers in the country – more easily accessible to residents of Oakland County.

"Our dedicated and compassionate staff working in the 17,700 square-foot facility's home-like setting made a comfortable healing place for patients," said Dr. Klamerus. "That same cancer expertise and warm atmosphere continues today.

"As our patient counts and services grew through the years, we realized that we needed to accommodate the continual growth, both in our clinics and with Karmanos' integrative services, to continue to provide the most advanced technology and array of clinic and complementary services our patients and their families deserve."    

Karmanos' Weisberg Center's clinic visits increased by more than 30 percent from fiscal years 2015 to 2018. Since the Leah A. Davidson Healing Arts program launched seven years ago, offering art and music therapy, gentle yoga, Tai Chi, Reiki therapy, Mindfulness Stress Reduction, and more, Karmanos has seen a 60 percent jump in demand for these services. In addition, those impacted by cancer have participated in an average of 3,000 visits to support groups annually. Many of the complementary services are offered at no cost and are open to all cancer patients, even those treated elsewhere. 

Building the addition of the $16 million state-of-the-art Gamma Knife suite with adjoining PET and MRI area, and clinic rooms, is the first in a two-phase expansion project that started in mid-2018 and recently completed.  

Karmanos' phase two expansion is underway and is expected to be completed in 2022. This will include an additional $30 million investment to expand the facility to approximately 64,000 square feet. The expansion will enhance clinic and infusion areas, radiation, radiology and imaging services, pharmacy and laboratory, as well as complementary services, to accommodate the continual growth of patient services – both in clinic and with Karmanos' supportive services at its Farmington Hills location. The total project is being financed with internal funds and philanthropy.

Dr. Klamerus added, "We realize patients have options when it comes to their health care needs. That's why at Karmanos, our comprehensive cancer center team is committed to offering the most advanced cancer care, research, education, and integrative and supportive services to our patients, as well as their loved ones."

For more information on Gamma Knife or other cancer services offered at Karmanos, call 1-800-KARMANOS (1-800-527-6266) or visit www.karmanos.org.

About the Barbara Ann Karmanos Cancer Institute
Karmanos Cancer Institute is headquartered in Detroit, with 16 locations throughout Michigan. As part of McLaren, Karmanos is the largest cancer care and research network in the state. It is among the nation's best cancer centers as one of the National Cancer Institute-designated comprehensive cancer centers in the United States and the only one located in metro Detroit. Karmanos cancer experts focus solely on cancer to prevent, detect and treat as well as eradicate all forms of cancer. Its long-term partnership with the Wayne State University School of Medicine enhances the collaboration of critical research and academics related to cancer care. For more information, call 1-800-KARMANOS (800-527-6266) or visit www.karmanos.org. Follow Karmanos on Facebook, Twitter and YouTube.

SOURCE Barbara Ann Karmanos Cancer Institute

Related Links

http://www.karmanos.org

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.